Forestar Group (FOR) Jumps 5.44% on January 14

Equities Staff |

Forestar Group (FOR) was among the biggest gainers on the Russell 2000 for Thursday January 14 as the stock popped 5.44% to $9.40, representing a gain of $0.485 per share. Some 271,934 shares traded hands on 1,273 trades, compared with an average daily volume of 280,424 shares out of a total float of 33.62 million. The stock opened at $8.95 and traded with an intraday range of $9.51 to $8.82.

After today's gains, Forestar Group reached a market cap of $315.82 million. Forestar Group has had a trading range between $16.35 and $8.86 over the last year, and it had a 50-day SMA of $12.07 and a 200-day SMA of $13.32.

Forestar Group Inc is a real estate and oil and gas company. The Company owns 113,000 acres of real estate including about 102,000 acres with timber. It also has 960,000 net acres of oil and gas mineral interests in the continental U.S.

Forestar Group is based out of Austin, TX and has some 150 employees. Its CEO is Phillip J. Weber.

For a complete fundamental analysis analysis of Forestar Group, check out Equities.com’s Stock Valuation Analysis report for FOR. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Breathtec BioMedical Inc.

Breathtec Biomedical Inc is a medical diagnostics company. It is engaged in developing & commercializing breath analysis devices for the early detection of infections & life threatening diseases including cancers,…

Private Markets

Spotify

Spotify is a online music service offering providing digital content from a range of record labels and artists. Users can browse through the interface by artist, album, genre, playlist, record…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…